Nautilus Biotechnology, Inc.
NAUT
$0.6884
-$0.0246-3.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.06% | -18.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.61% | -8.12% | |||
| Operating Income | -4.61% | 8.12% | |||
| Income Before Tax | -6.98% | 8.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.98% | 8.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.98% | 8.68% | |||
| EBIT | -4.61% | 8.12% | |||
| EBITDA | -5.18% | 8.34% | |||
| EPS Basic | -6.71% | 8.77% | |||
| Normalized Basic EPS | -23.69% | 8.80% | |||
| EPS Diluted | -6.71% | 8.77% | |||
| Normalized Diluted EPS | -23.69% | 8.80% | |||
| Average Basic Shares Outstanding | 0.27% | 0.11% | |||
| Average Diluted Shares Outstanding | 0.27% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||